These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22182303)

  • 1. Supervised regularized canonical correlation analysis: integrating histologic and proteomic measurements for predicting biochemical recurrence following prostate surgery.
    Golugula A; Lee G; Master SR; Feldman MD; Tomaszewski JE; Speicher DW; Madabhushi A
    BMC Bioinformatics; 2011 Dec; 12():483. PubMed ID: 22182303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised regularized canonical correlation analysis: integrating histologic and proteomic data for predicting biochemical failures.
    Golugula A; Lee G; Master SR; Feldman MD; Tomaszewski JE; Madabhushi A
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():6434-7. PubMed ID: 22255811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer.
    Lee G; Singanamalli A; Wang H; Feldman MD; Master SR; Shih NN; Spangler E; Rebbeck T; Tomaszewski JE; Madabhushi A
    IEEE Trans Med Imaging; 2015 Jan; 34(1):284-97. PubMed ID: 25203987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
    Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
    Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule.
    Vau N; Henriques V; Cheng L; Blanca A; Fonseca J; Montironi R; Cimadamore A; Lopez-Beltran A
    Hum Pathol; 2019 Nov; 93():6-15. PubMed ID: 31442520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
    Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
    Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy.
    Saad F; Latour M; Lattouf JB; Widmer H; Zorn KC; Mes-Masson AM; Ouellet V; Saad G; Prakash A; Choudhury S; Han G; Karakiewicz P; Richie JP
    J Urol; 2017 Apr; 197(4):1034-1040. PubMed ID: 27725152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided prognosis: predicting patient and disease outcome via quantitative fusion of multi-scale, multi-modal data.
    Madabhushi A; Agner S; Basavanhally A; Doyle S; Lee G
    Comput Med Imaging Graph; 2011; 35(7-8):506-14. PubMed ID: 21333490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatome: a combined anatomical and disease based MRI atlas of the prostate.
    Rusu M; Bloch BN; Jaffe CC; Genega EM; Lenkinski RE; Rofsky NM; Feleppa E; Madabhushi A
    Med Phys; 2014 Jul; 41(7):072301. PubMed ID: 24989400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
    Freedland SJ; Kane CJ; Presti JC; Terris MK; Amling CL; Dorey F; Aronson WJ
    J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Trock BJ; Humphreys EB; Partin AW; Han M; Gonzalgo ML
    J Urol; 2008 May; 179(5):1780-4; discussion 1784. PubMed ID: 18343439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a five gene signature to predict time to biochemical recurrence after radical prostatectomy.
    Corradi JP; Cumarasamy CW; Staff I; Tortora J; Salner A; McLaughlin T; Wagner J
    Prostate; 2021 Jul; 81(10):694-702. PubMed ID: 34002865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy.
    Liesenfeld L; Kron M; Gschwend JE; Herkommer K
    J Urol; 2017 Jan; 197(1):143-148. PubMed ID: 27418452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.
    Erho N; Crisan A; Vergara IA; Mitra AP; Ghadessi M; Buerki C; Bergstralh EJ; Kollmeyer T; Fink S; Haddad Z; Zimmermann B; Sierocinski T; Ballman KV; Triche TJ; Black PC; Karnes RJ; Klee G; Davicioni E; Jenkins RB
    PLoS One; 2013; 8(6):e66855. PubMed ID: 23826159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
    Lee G; Veltri RW; Zhu G; Ali S; Epstein JI; Madabhushi A
    Eur Urol Focus; 2017 Oct; 3(4-5):457-466. PubMed ID: 28753763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy.
    Luiting HB; van Leeuwen PJ; Remmers S; Donswijk M; Busstra MB; Bakker IL; Brabander T; Stokkel M; van der Poel HG; Roobol MJ
    J Urol; 2020 Sep; 204(3):503-510. PubMed ID: 32149575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensionality reduction-based fusion approaches for imaging and non-imaging biomedical data: concepts, workflow, and use-cases.
    Viswanath SE; Tiwari P; Lee G; Madabhushi A;
    BMC Med Imaging; 2017 Jan; 17(1):2. PubMed ID: 28056889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.